Improving lung cancer screening access and effectiveness
Increasing Equity in Lung Cancer Screening
NA · Indiana University · NCT06360822
This study is trying to improve lung cancer screening in the emergency department by talking to patients and staff to see how well the process works and how it can be made better.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 144 (estimated) |
| Ages | 50 Years to 80 Years |
| Sex | All |
| Sponsor | Indiana University (other) |
| Locations | 1 site (Indianapolis, Indiana) |
| Trial ID | NCT06360822 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance the Emergency Department Lung Cancer Screening (ED-LCS) intervention by conducting qualitative interviews with key stakeholders to refine the approach. It will pilot test the intervention to evaluate its efficacy, acceptability, and feasibility among eligible patients. Additionally, the study will gather in-depth descriptions of stakeholders' experiences to inform future improvements to the screening process.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 50-80 who have a history of smoking and meet specific criteria for lung cancer screening.
Not a fit: Patients who do not speak English or Spanish, have severe psychiatric conditions, or are currently enrolled in hospice care may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more effective lung cancer screening, ultimately improving early detection and patient outcomes.
How similar studies have performed: Other studies have shown promise in improving lung cancer screening interventions, suggesting that this approach may build on existing successful strategies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Eligible for LCS (50-80 years old, smoked in past 15 years, and smoked at least 20 pack years) Exclusion Criteria: * • Non-English/Spanish speaking * Decompensated psychiatric illness (suicidal, homicidal, psychosis). Will confirm with attending physicians at time of enrollment * Intoxicated with alcohol or drugs * Cannot provide reliable follow up contact information (cell phone) * Presenting to the ED with a life-threatening condition * Have received chest CT scan in past 12 months * Already enrolled in LCS * Hospice enrolled
Where this trial is running
Indianapolis, Indiana
- Eskenazi Health — Indianapolis, Indiana, United States (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Lung Cancer